Consistent with our findings for AGT risk, both the insulin demand–adequacy method and the RAD method performed best for evaluating the risk of diabetes in the late phase of the OGTT, as compared with the other two OGTT phases, and the RAD method was more stable and efficient than the insulin demand–adequacy method (ESM Table 7). The gene discussed is AGT; the disease is diabetes mellitus.